TW341574B - METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. - Google Patents

METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Info

Publication number
TW341574B
TW341574B TW085115392A TW85115392A TW341574B TW 341574 B TW341574 B TW 341574B TW 085115392 A TW085115392 A TW 085115392A TW 85115392 A TW85115392 A TW 85115392A TW 341574 B TW341574 B TW 341574B
Authority
TW
Taiwan
Prior art keywords
compositions
dioxolane
synthesis
configuration
methods
Prior art date
Application number
TW085115392A
Other languages
English (en)
Chinese (zh)
Inventor
Mansour Tarek
Cimpoia Alex
Bednarski Krzysztof
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of TW341574B publication Critical patent/TW341574B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW085115392A 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. TW341574B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration

Publications (1)

Publication Number Publication Date
TW341574B true TW341574B (en) 1998-10-01

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085115392A TW341574B (en) 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.

Country Status (27)

Country Link
US (4) US5922867A (enExample)
EP (1) EP0970074B1 (enExample)
JP (1) JP3229990B2 (enExample)
KR (1) KR100406159B1 (enExample)
CN (1) CN1080263C (enExample)
AP (1) AP879A (enExample)
AT (1) ATE214699T1 (enExample)
AU (1) AU706328B2 (enExample)
BR (1) BR9612351A (enExample)
CA (1) CA2237730C (enExample)
DE (1) DE69620042T2 (enExample)
DK (1) DK0970074T3 (enExample)
EA (1) EA000844B1 (enExample)
ES (1) ES2172697T3 (enExample)
GB (1) GB9525606D0 (enExample)
HU (1) HU224076B1 (enExample)
IL (3) IL124663A (enExample)
IN (1) IN187349B (enExample)
MX (1) MX9804701A (enExample)
NO (1) NO309901B1 (enExample)
NZ (1) NZ323855A (enExample)
OA (1) OA11094A (enExample)
PL (1) PL188447B1 (enExample)
PT (1) PT970074E (enExample)
TW (1) TW341574B (enExample)
WO (1) WO1997021706A1 (enExample)
ZA (1) ZA9610544B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518899A (ja) 1997-04-07 2001-10-16 トライアングル ファーマシューティカルズ,インコーポレイティド 他の抗ウイルス剤との組合せにおけるmkc−442の使用
EP1104415B1 (en) 1998-08-12 2004-11-10 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
US6979561B1 (en) * 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
EA004767B1 (ru) 1998-12-23 2004-08-26 Шайре Байокем Инк. Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
WO2000047759A1 (en) * 1999-02-11 2000-08-17 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
JP2003510271A (ja) * 1999-09-24 2003-03-18 シャイアー・バイオケム・インコーポレイテッド ヌクレオシドアナログを使用したウィルス感染の処置または予防のための方法
US6566365B1 (en) 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
KR100517163B1 (ko) * 2000-02-10 2005-09-26 미쯔이카가쿠 가부시기가이샤 1-인산화 당유도체 아노머의 선택적인 제조방법 및뉴클레오사이드의 제조방법
EP1265890B1 (en) * 2000-02-11 2007-04-18 Shire BioChem Inc. Stereoselective synthesis of nucleoside analogues
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
CN1503796B (zh) 2001-03-01 2012-07-04 三角药品公司 顺-ftc的多晶型物及其它晶型
AU2002329970A1 (en) * 2001-09-04 2003-03-18 Isis Pharmaceuticals, Inc. Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
CA2465682A1 (en) * 2001-11-02 2003-05-08 Shire Biochem Inc. Methods of treating leukemia
KR100978904B1 (ko) 2001-12-14 2010-08-31 파마셋 인코포레이티드 바이러스 감염 치료용 n4-아실사이토신 뉴클레오사이드
ATE548366T1 (de) * 2002-01-25 2012-03-15 Shire Biochem Inc Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen
EP1534255B1 (en) 2002-08-06 2011-01-19 Pharmasset, Inc. Processes for preparing 1,3-dioxolane nucleosides
ES2394304T3 (es) 2002-10-15 2013-01-30 Exxonmobil Chemical Patents, Inc. Sistema de múltiples catalizadores para la polimerización de olefinas y polímeros producidos a partir de éstos
DE10335061B4 (de) 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
WO2005074654A2 (en) * 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
JP7337539B2 (ja) 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
NO932286L (no) * 1992-06-22 1993-12-23 Lilly Co Eli Stereoselektiv anion-glykosyleringsprosess

Also Published As

Publication number Publication date
ES2172697T3 (es) 2002-10-01
CN1208414A (zh) 1999-02-17
DE69620042T2 (de) 2002-10-17
IL144155A (en) 2003-07-06
CN1080263C (zh) 2002-03-06
EA000844B1 (ru) 2000-06-26
AP879A (en) 2000-10-02
CA2237730A1 (en) 1997-06-19
EP0970074A1 (en) 2000-01-12
ZA9610544B (en) 1997-07-29
HUP9901050A3 (en) 2001-05-28
PL327443A1 (en) 1998-12-07
DK0970074T3 (da) 2002-07-15
NZ323855A (en) 1999-11-29
US20030060476A1 (en) 2003-03-27
US6069250A (en) 2000-05-30
KR100406159B1 (ko) 2004-11-16
GB9525606D0 (en) 1996-02-14
AU706328B2 (en) 1999-06-17
NO982716D0 (no) 1998-06-12
IL144155A0 (en) 2002-05-23
NO982716L (no) 1998-06-12
US20020058670A1 (en) 2002-05-16
WO1997021706A1 (en) 1997-06-19
HK1017886A1 (en) 1999-12-03
DE69620042D1 (de) 2002-04-25
CA2237730C (en) 2001-12-04
AU1089397A (en) 1997-07-03
EA199800555A1 (ru) 1999-02-25
EP0970074B1 (en) 2002-03-20
ATE214699T1 (de) 2002-04-15
HU224076B1 (hu) 2005-05-30
MX9804701A (es) 1998-10-31
BR9612351A (pt) 1999-07-13
JP2000501714A (ja) 2000-02-15
AP9801252A0 (en) 1998-06-30
OA11094A (en) 2003-03-13
NO309901B1 (no) 2001-04-17
US5922867A (en) 1999-07-13
PT970074E (pt) 2002-09-30
IL124663A (en) 2001-10-31
IN187349B (enExample) 2002-03-30
KR19990072141A (ko) 1999-09-27
PL188447B1 (pl) 2005-02-28
IL124663A0 (en) 1998-12-06
HUP9901050A2 (hu) 2001-04-28
JP3229990B2 (ja) 2001-11-19

Similar Documents

Publication Publication Date Title
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
HU912253D0 (en) Process for the production of purinyl-phosphonic acid derivatives
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
TW366350B (en) Processes for the diastereoselective synthesis of nucleosides
BR9302434A (pt) Processo para preparar um nucleosidio enriquecido com beta-anomero
FI104176B1 (fi) Menetelmä nukleosidien uusien antiviraalisten forfolipidijohdannaisten valmistamiseksi
MX2007003085A (es) Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
EG20193A (en) Process for preparing of 1,3- oxathiolane nucleoside analogues
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
DE3477791D1 (en) Nucleoside process
FI885094A7 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
EP0330992A3 (en) Novel cyclobutane derivatives, processes for their preparation and pharmaceutical compositions comprising them
AU2003251936A1 (en) Process for the preparation of 9-beta-anomeric nucleoside analogs
EP0311694A4 (en) Nucleoside derivatives and process for their preparation
NO974512D0 (no) Fremgangsmåte for syntese av nukleosid-analoger
JPS6426594A (en) Nucleotides and antitumor agent
MX9604880A (es) Procedimiento para la sintesis diasteroselectiva de analogos de nucleosido.
GEP20002030B (en) Diastereoselective Synthesis of Nucleosides
JPS5634698A (en) N6-acyl-3'-o(o-nitrobenzyl)adenosine-5'-monophosphate and its preparation
CA2188306A1 (en) Process for the diastereoselective synthesis of nucleoside analogues